What is the primary goal of the Laboratory Act?


The Laboratory Access for Beneficiaries Act aims to “delay the next round of the (PAMA) data reporting by one year to ensure that all applicable laboratories that are required to report private payer data have the necessary time to do so.” Stakeholders have long believed the flawed data collection process is responsible for significant year to year cuts to crucial clinical diagnostics and ultimately the erosion of Medicare laboratory benefits.

This question was answered in an edition of our Laboratory Compliance Manager. For more hot topics relating to laboratory services, please visit our store or call us at 1.800.252.1578, ext. 2.


CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.